Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS CIPLA IPCA LABS/
CIPLA
 
P/E (TTM) x 51.7 32.2 160.5% View Chart
P/BV x 5.4 5.2 104.0% View Chart
Dividend Yield % 0.3 0.6 56.8%  

Financials

 IPCA LABS   CIPLA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
CIPLA
Mar-23
IPCA LABS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,0621,185 89.6%   
Low Rs768852 90.1%   
Sales per share (Unadj.) Rs243.0281.9 86.2%  
Earnings per share (Unadj.) Rs19.435.1 55.2%  
Cash flow per share (Unadj.) Rs29.749.7 59.8%  
Dividends per share (Unadj.) Rs4.008.50 47.1%  
Avg Dividend yield %0.40.8 52.4%  
Book value per share (Unadj.) Rs230.3289.2 79.6%  
Shares outstanding (eoy) m253.70807.15 31.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.6 104.2%   
Avg P/E ratio x47.229.0 162.7%  
P/CF ratio (eoy) x30.820.5 150.2%  
Price / Book Value ratio x4.03.5 112.8%  
Dividend payout %20.624.2 85.3%   
Avg Mkt Cap Rs m232,120822,164 28.2%   
No. of employees `000NANA-   
Total wages/salary Rs m12,87638,301 33.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,642227,531 27.1%  
Other income Rs m1,5185,121 29.6%   
Total revenues Rs m63,160232,653 27.1%   
Gross profit Rs m9,03348,079 18.8%  
Depreciation Rs m2,61611,721 22.3%   
Interest Rs m4821,095 44.0%   
Profit before tax Rs m7,45340,384 18.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,53412,029 21.1%   
Profit after tax Rs m4,91928,355 17.3%  
Gross profit margin %14.721.1 69.3%  
Effective tax rate %34.029.8 114.1%   
Net profit margin %8.012.5 64.0%  
BALANCE SHEET DATA
Current assets Rs m51,893168,051 30.9%   
Current liabilities Rs m18,05850,333 35.9%   
Net working cap to sales %54.951.7 106.1%  
Current ratio x2.93.3 86.1%  
Inventory Days Days5173 69.9%  
Debtors Days Days67 90.0%  
Net fixed assets Rs m34,336117,318 29.3%   
Share capital Rs m2541,614 15.7%   
"Free" reserves Rs m58,167231,845 25.1%   
Net worth Rs m58,420233,460 25.0%   
Long term debt Rs m6,5180-   
Total assets Rs m86,229290,067 29.7%  
Interest coverage x16.537.9 43.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.8 91.1%   
Return on assets %6.310.2 61.7%  
Return on equity %8.412.1 69.3%  
Return on capital %12.217.8 68.8%  
Exports to sales %42.922.6 189.4%   
Imports to sales %13.38.9 149.4%   
Exports (fob) Rs m26,43451,516 51.3%   
Imports (cif) Rs m8,17820,202 40.5%   
Fx inflow Rs m26,43464,282 41.1%   
Fx outflow Rs m8,17820,202 40.5%   
Net fx Rs m18,25744,080 41.4%   
CASH FLOW
From Operations Rs m8,05832,377 24.9%  
From Investments Rs m-7,250-23,885 30.4%  
From Financial Activity Rs m5,072-9,583 -52.9%  
Net Cashflow Rs m5,881-968 -607.6%  

Share Holding

Indian Promoters % 46.3 13.4 344.7%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 44.8 50.0 89.6%  
FIIs % 10.3 25.7 39.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 66.5 80.7%  
Shareholders   82,809 425,731 19.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on IPCA Labs vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Cipla Share Price Performance

Period IPCA Labs Cipla S&P BSE HEALTHCARE
1-Day 3.35% 1.94% 1.18%
1-Month 4.27% 1.25% -0.75%
1-Year 56.49% 68.02% 61.82%
3-Year CAGR 9.46% 22.53% 18.16%
5-Year CAGR 20.88% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.